Skip to content

NIH K01 Grant 2026: Eligibility, Salary, Page Limits

Updated 26 official sources

Quick Answer: An NIH K01 grant, the Mentored Research Scientist Development Award, pays for 3 to 5 years of mentored research and career development at 75% effort (9 person-months), with salary limits of $75,000 to $100,000 plus fringe at most institutes, according to the parent K01, PA-24-176, and NIH's institute table.

Full answer and how we checked it

If you're applying, K01 eligibility requires a research or health-professional doctorate, U.S. citizenship, non-citizen national status or permanent residence by the time of award, and no current or past PD/PI role on an R01, P01, P50 or another major individual K award such as a K08, K23 or K99/R00. Research support runs $20,000 to $50,000 a year at most institutes. NIAID takes K01s in all of its research areas for due dates from October 12, 2025 (NOT-AI-25-038), but only without an independent clinical trial. The Candidate Information and Goals for Career Development and the Research Strategy share one 12-page limit under NIH's Table of Page Limits. The next new-application due date is February 12, 2027, and NIH replaces the K01 code with KR1 for due dates on or after October 12, 2027.

Data note: K01 award counts and medians come from Grantsights analysis of NIH RePORTER (opens in a new tab) records for FY2024 to FY2026, pulled November 14, 2026. Salary and research-support limits come from NIH's institute table for PA-24-176 on the same date. Institutes can change these limits between cycles.

In this guide
K01 questionWhat the parent K01 (PA-24-176) says, checked November 14, 2026
Who can applyA research or health-professional doctorate, citizenship, non-citizen national status or permanent residence by award, and a full-time appointment at the applicant institution
Who can'tCurrent or former PDs/PIs of an R01, P01 or P50, and holders of other major individual K awards such as the K01, K07, K08, K22, K23, K25, K76 or K99/R00; past R03, R21, R34, R36 and SBIR/STTR PIs stay eligible
Years since degreeNo limit in the parent; some institutes set priorities (see the institute table below)
Protected effortAt least 9 person-months, which is 75% of full-time professional effort
Project periodUp to 5 years; NIEHS and NINR cap the K01 at 3, NIBIB at 4
Reference letters3 to 5, sent by referees through eRA Commons; no page limit
Next due datesNew: February 12, 2027. Resubmission: March 12, 2027 (the November 12, 2026 date has passed)
Parent expiresMay 8, 2027; the June and July 2027 K dates need a reissued parent

Grantsights read the eligibility, effort and Key Dates sections of PA-24-176 (opens in a new tab) and NIH's institute-specific K table for PA-24-176 (opens in a new tab) on November 14, 2026. A February 12, 2027 application goes to review in July 2027 and council in October 2027, with an earliest start of December 2027. The full NIH calendar for K and other codes is in NIH grant deadlines.

The NIH K01 career development award is one of the most misunderstood mechanisms in the NIH funding portfolio. It's frequently confused with other K awards, applied for by investigators who don't meet its eligibility requirements, or submitted by applicants who don't understand how different K award review is from R01 review. If you want the active parent announcement, award data, and direct application links in one place, review the live Parent K01 page for projects without a clinical trial and the live Parent K01 page for projects with a clinical trial before you commit to a branch.

This page explains what the K01 is, who it's for, what the application requires, and what the data says about K-to-R01 transition rates for awardees.

From Manusights, our sister product

Planning a K award? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a K99 or any other K award. Back within 3 business days of your upload.

Order a grant review

The K Award Series: Which One Is Which

The K series targets different career stages and disciplines. Before deciding the K01 is the right mechanism, you need to confirm it matches your specific situation.

AwardTarget PopulationKey Requirement
K01PhD researchers pivoting to a new field or building new skillsResearch or health-professional doctorate; no years-since-degree limit in the parent
K08Physician-scientists pursuing basic research trainingMD or equivalent; early career
K23Physician-scientists pursuing patient-oriented researchMD or DO; must conduct patient-oriented research directly with human subjects
K25Quantitative scientists transitioning into biomedical researchPhD in math, statistics, engineering, or similar; non-biomedical background required
K99/R00Late-stage postdocs transitioning to a first faculty positionNo more than 4 years post-degree at application (with some extensions); unique: non-citizens may be eligible at certain stages

The K01 is specifically for PhD researchers - in basic science, behavioral science, or clinical science - who need a protected period to develop expertise in a new research area. It's a career transition award, not a research project award. If you are comparing broader K-series options against institute-specific transition mechanisms, review the live NIAID Career Transition Award (K22) page alongside the NIH Research Training and Career Development (opens in a new tab) page.

NIDCD also runs a narrower pathway for postdoctorate Au.D./Ph.D. audiologists, so applicants in hearing science should review the live NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) page. If the project does not involve an applicant-led clinical trial, compare it with the live NIDCD Audiologists K01 page for projects without an independent clinical trial. If the applicant will lead the trial, compare it with the live NIDCD Audiologists K01 page for projects with a clinical trial. Established NIDCD investigators considering a shorter career-enhancement route instead of an early-career K award should also compare the live NIDCD K18 page for projects without a clinical trial, the live NIDCD K18 page for projects with a clinical trial, and the live NIDCD K18 page for basic experimental studies with humans.

If you're an established clinician-investigator primarily looking for protected mentoring time in patient-oriented research rather than a mentored early-career K01, compare that against the live Parent K24 page for patient-oriented research without an independent clinical trial, the live Parent K24 page for patient-oriented research with an independent clinical trial, and the live Parent K24 page for basic experimental studies with humans.

Quantitative investigators choosing between K01 and K25 should compare the live Parent K25 page for projects without a clinical trial, the live Parent K25 page for projects with a clinical trial, and the live Parent K25 page for basic experimental studies with humans.


Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

What the K01 Is NOT For

Before getting into what the K01 requires, it's worth being direct about what it isn't designed for.

It's not for postdocs seeking their first faculty position. That pathway is the K99/R00 (Pathway to Independence Award), which is specifically designed to support the postdoc-to-faculty transition. K99/R00 applicants typically still have several years of postdoc work ahead of them and plan to use the K99 phase to finish training before transitioning to an R00 phase at a new institution. If your project does not include a clinical trial, compare your fit against the live NIH Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) page before you settle on the NOFO. If the transition project does include a clinical trial, use the live NIH Pathway to Independence Award (K99/R00 Clinical Trial Required) page to confirm that you are reading the right branch.

It's not for clinicians doing patient-oriented research with human subjects. If you have an MD or DO and your research directly involves patients, the K23 is the appropriate mechanism. The K23's eligibility requirements and review criteria are calibrated for clinician-scientists. For the active parent branches, review the live Parent K23 page for projects without a clinical trial. If the patient-oriented project is a basic experimental study with humans, compare it with the live Parent K23 page for basic experimental studies with humans. If the patient-oriented project includes an independent clinical trial, compare it with the live Parent K23 page for projects with a clinical trial.

It's a hard sell for very early postdocs. The parent K01 sets no minimum years of postdoctoral work, but reviewers score the candidate's record, so you need enough of a track record to show that a K01 investment is well placed. NIBIB doesn't take postdocs for the K01 at all.


K01 Eligibility Requirements

K01 eligibility comes down to 4 rules in PA-24-176 (opens in a new tab): a research or health-professional doctorate, U.S. citizenship, non-citizen national status or permanent residence by the time of award, a full-time appointment at the applicant institution, and no current or past PD/PI role on an R01, P01, P50 or another major individual K award. Institute rules add priorities on top.

Degree: A research or health-professional doctoral degree (PhD, MD, or equivalent) in a relevant field. K01 applicants typically hold a PhD in a basic or behavioral science discipline. Clinicians with MDs who want to pursue basic research training sometimes use K01, but they should compare carefully with the live Parent K08 page for projects without a clinical trial and the live Parent K08 page for projects with a clinical trial.

Experience: The parent K01 has no years-since-degree window. Several institutes used fixed postdoc-year windows in the past, which is why many guides still quote a range like "2 to 7 years." Today the limits are institute priorities: NICHD favors candidates within 6 years of finishing a postdoc or clinical fellowship, NIEHS favors those within 3 years of starting a first faculty job, NIBIB funds junior faculty within 10 years of the PhD, fellowship or residency, and NCI considers K01 candidates who haven't been promoted to associate professor. NIDDK dropped its minimum and maximum postdoc years for applications submitted from January 25, 2025 (NOT-DK-25-001 (opens in a new tab)).

Citizenship: You must be a U.S. citizen, a non-citizen national, or a lawful permanent resident by the time of award, not by the time you apply. Unlike the K99/R00, which allows non-citizens, K01 requires citizenship or permanent residence at award time.

No prior R01-level or K award as PD/PI: Current and former PDs/PIs of an R01, P01 or P50, project leads on P01 or P50 grants, and holders of other major individual K awards (the notice names K01, K07, K08, K22, K23, K25, K76 and K99/R00) aren't eligible. Past PIs of an R03, R21/R33, R34, R36 or SBIR/STTR grant stay eligible, as do K38 scholars and people appointed to institutional K12 or KL2 programs.

Institutional appointment: You need a "full-time" appointment at the applicant institution at the time of award. VA effort doesn't count toward that full-time requirement. Multiple PDs/PIs aren't allowed.

A K01 can also restart a career. PA-24-176 says it can support people training in a new field or returning after "a hiatus in their research career because of illness or pressing family circumstances," and NIAMS prioritizes K01 applicants with a change in scientific focus or a break of more than 1 year from research.

Does NIAID Accept K01 Applications?

Yes: NIAID accepts K01 applications in every area of its mission for due dates from October 12, 2025 onward, under NOT-AI-25-038 (opens in a new tab), released July 9, 2025. That notice replaced NOT-AI-19-061, which had limited NIAID's K01 to epidemiology and data science, so older advice that "NIAID only funds K01s in epidemiology" is out of date.

Two limits remain. NIAID takes the K01 only through the clinical-trial-not-allowed parent, PA-24-176; it isn't a participating institute on PA-24-175 (opens in a new tab), the clinical-trial-required parent. And NIAID's row in NIH's institute table lists no K01 salary or research-support figure, so ask NIAID program staff what budget to request.

The change shows up in the award records. According to NIH RePORTER, NIAID had 58 active K01 projects in FY2026, 17 of them new, up from 11 new K01s in FY2025. One investigator at Duke University received $211,008 in FY2026 for a new NIAID K01 on antibody responses to HHV-8 (1K01AI200492-01), and a University of Washington K01 on IL-15 and vaccine responses in nonhuman primates came in at $189,000 (1K01AI200007-01A1). The 17 new FY2026 awards mix lab projects like those two with epidemiology and modeling work, such as drug-resistant gonorrhea models at Harvard's school of public health.


K01 Budget: What NIH Pays and What It Doesn't

K01 salary limits run from $75,000 to $100,000 a year plus fringe at most institutes, and research support from $20,000 to $50,000 a year, according to NIH's institute-specific table for PA-24-176 (opens in a new tab), checked November 14, 2026. The parent notice itself names no dollar figure; it says the participating institutes set salary and research development support. Don't assume all K01s pay the same.

K01 Salary, Research Support and Awards by Institute

The award columns are Grantsights analysis of K01 records in NIH RePORTER (opens in a new tab) for FY2026 (October 2025 to September 2026), pulled November 14, 2026. "Active" counts every funded K01 project that year, including continuing years; "new" counts first-year awards. The median is total costs, so it includes the 8% indirect rate NIH allows on K awards.

InstituteSalary limit (plus fringe)Research support per yearK01-specific ruleFY2026 K01s: active (new)Median FY2026 award
NIA$75,000$20,000Up to 5 years176 (31)$125,888
NHLBI$100,000$30,000Population science encouraged; 6-year cap on cumulative K01 support132 (26)$161,646
NIDDK$90,000$25,000, plus $1,500 for the K awardees' workshopNo minimum or maximum postdoc years128 (31)$151,841
NIDA$100,000$50,000Contact a program official first127 (25)$188,283
NIMH$90,000$50,000May cap at 4 years; priority to pre-tenure early-stage investigators110 (20)$178,516
NIAIDNot listedNot listedAll mission areas since October 12, 2025; no independent clinical trial58 (17)$136,919
NCI$100,000$50,000Not yet associate professor; priority to cancer control, population science, prevention and data science44 (14)$175,492
NIMHD$75,000$25,000Health outcome and population requirements39 (2)$130,971
NIAAA$90,000$50,000Faculty or equivalent position at award35 (3)$173,076
NICHD$75,000$25,000Only child abuse and neglect, population science, rehabilitation and Down syndrome27 (6)$130,072
NIAMS$75,000Not listedPriority to a change of field or a break of more than 1 year23 (4)$122,563
NIEHS$75,000$50,0003-year award; within 3 years of a first faculty job9 (2)$161,771
NIBIB$90,000$40,000Up to 4 years; junior faculty only, no postdocs6 (2)$155,694

Smaller K01 funders on the same table: NIDCD ($75,000 and $30,000), NCCIH ($75,000 and $25,000), NINR ($100,000 and $25,000, 3 years), NIDCR ($100,000 and $25,000), NHGRI ($40,000 research support), and NINDS, which joined the parent K01 on May 26, 2026 and pays $75,000 and $30,000 to postdocs but up to $150,000 and $75,000 to faculty. NLM allows up to $125,000 for candidates with academic appointments and $75,000 for those with up to 4 years of postdoc experience.

Grantsights analysis of the same RePORTER records shows NIH-wide K01 totals falling for three straight years: 1,204 active K01 projects in FY2024, 1,086 in FY2025 and 1,026 in FY2026 (a few are CDC and AHRQ K01s, which RePORTER also lists). New K01s dropped from 235 in FY2024 to 165 in FY2025, then recovered to 202 in FY2026. If your institute funded only a handful of new K01s last year, like NIMHD (2) or NIAAA (3), ask its program staff whether a K01 is the right route before you write. A K23, K25 or institutional K12 may be the better route. For named K01 recipients and award sizes by institute, see NIH K01 winners and award history.

What research support can pay for: PA-24-176 lists tuition and fees tied to career development, supplies, equipment and technical personnel, travel to research meetings or training, and statistical services. Salary for mentors and administrative staff isn't allowed.

Duration: 3 to 5 years under the parent. Five-year awards suit candidates who need a longer development period, and three-year awards suit those with a focused skill gap. Check your institute first: NIEHS and NINR cap the K01 at 3 years, NIBIB at 4, and NIMH may cut a 5-year request to 4.

NIH salary cap (awards issued from January 1, 2026): $228,000, per NIH's salary cap summary (opens in a new tab), which still listed it as the latest figure on November 14, 2026. The K01 limits above sit far below that cap, so the institute limit is what binds. Your institution pays any salary above the K01 limit from its own funds, and its commitment letter should say so. How the cap and the K limits interact for other K codes is in K award salary limits and the NIH salary cap.


The 75% Protected Time Requirement

K01 awardees must commit a minimum of 9 person-months (75% effort) to K award activities during the award period.

Up to 25% of your time can be clinical duties, teaching, or other complementary work, as long as it doesn't detract from the career development plan. The K01 doesn't pay for that 25%, though you can be paid from other research grants for effort the K01 doesn't require.

In the final 2 years of a 3- to 5-year mentored K, you can cut K01 effort from 75% to 50%, but only if you become PD/PI of a peer-reviewed research award from NIH, another federal agency or a non-federal source, and your combined research effort stays at 75% or more. NIH restated this rule in a June 2026 Extramural Nexus post on K award effort (opens in a new tab). The reduction needs prior approval; it isn't automatic.

Here's where many K01 applications fail at implementation rather than at review: institutional commitment letters that don't genuinely guarantee 75% protected time. A letter from a department chair saying "we support Dr. X's K01 application" isn't the same as a letter committing to backfill clinical coverage, reducing teaching loads, and genuinely freeing up 9 months of protected time.

If your department needs you to teach 3 courses per year and run clinic 3 days per week, you likely can't meet the 75% requirement - and submitting a K01 application in that situation sets you up for either a failed application (reviewers will probe protected time guarantees) or a compliance problem during the award period.

Get explicit written commitment from your chair before you apply, not during the application process.


K01 Page Limits

The K01 Research Strategy and the Candidate Information and Goals for Career Development share a combined 12-page limit, and the Specific Aims page is 1 page. NIH's Table of Page Limits (opens in a new tab) (last updated September 30, 2026, checked November 14, 2026) puts K01 in the same column as the other K awards, and the Parent K01 opportunity, PA-24-176 (opens in a new tab), says applicants must follow that table. The one that catches people is the 12-page limit: it covers the Candidate section and the Research Strategy "for both attachments combined."

K01 sectionPage limit
Specific Aims1 page
Candidate Information and Goals for Career Development plus Research Strategy12 pages combined
Introduction to a resubmission1 page
Plans and Statements of Mentor and Co-mentor(s)6 pages
Letters of Support from Collaborators, Contributors, and Consultants6 pages
Description of Institutional Environment1 page
Institutional Commitment to Candidate's Research Career Development1 page
Training in the Responsible Conduct of Research1 page
Project Summary30 lines
Project Narrative3 sentences
Biosketch (Common Form and NIH supplement)No page limit; length is set by the SciENcv format

Two rules sit outside the table. NIH's Grants Policy Statement, section 12.4.1.1 (opens in a new tab), requires "at least three (but no more than five)" reference letters for new and resubmission mentored K applications, and those letters have no page limit. Referees submit them through eRA Commons, not with the application, and PA-24-176 says an application without the required letters won't be reviewed. For due dates from January 25, 2025, NIH gave referees more structured instructions on the candidate's strengths, weaknesses and potential (NOT-OD-24-084 (opens in a new tab)), so send your referees the current instructions rather than an old template. Since May 8, 2026, NIH requires the Common Forms biosketch for these applications (NOT-OD-26-079 (opens in a new tab)); the old 5-page biosketch now stops a submission.

What the table doesn't tell you is how to split the 12 pages. Because the Candidate section and Research Strategy share one limit, every page of science you add is a page taken from the career development plan, which is the part K reviewers weigh most heavily. If your institute's K01 notice sets a different limit, the notice wins: NIH says funding opportunity instructions "always supersede" the general guide.

"ACT K01" and the 2027 Change to the K01 Code

If you searched "ACT K01" or "K01 ACT," there isn't an NIH program by that name. Grantsights checked every K01 announcement in the NIH Guide on October 1, 2026, and none has "ACT" in its title. The closest matches are:

  • K01 as an activity code. NIH calls K01 an activity code, the label for the type of award. The four K01 opportunities open now are PA-24-176 (independent clinical trial not allowed), PA-24-175 (clinical trial required), and two NIDCD audiologist K01s, PAR-24-149 and PAR-24-159. All four expire May 8, 2027.
  • A K01 tied to a law. The tobacco regulatory science K01s, RFA-OD-22-023 and RFA-OD-22-024, cited the Family Smoking Prevention and Tobacco Control Act. Both expired September 20, 2024.

The activity code itself is changing. Under NOT-OD-26-098 (opens in a new tab), released August 12, 2026, NIH will fold the K01, K21, K25 and K32 into one new code, KR1, for due dates on or after October 12, 2027. Current K opportunities will expire by July 13, 2027. NIH also says it "will no longer support 'Independent Clinical Trial Required' K award NOFOs." The Data Management and Sharing Plan change came early: under NOT-OD-26-120 (opens in a new tab), released October 5, 2026, K applications and active K awards no longer need a DMS Plan, effective immediately, so a K01 due February 12, 2027 doesn't need one. If you're planning a first K01 submission, the cycles before the July 2027 expirations are the last ones under the current K01 announcements.

Due dates. The parent K01s use NIH's standard K-series dates: February 12, June 12 and October 12 for new applications, and March 12, July 12 and November 12 for resubmissions, according to NIH's standard due dates table (opens in a new tab). A date that falls on a weekend or federal holiday moves to the next business day, which is why the October 12, 2026 date moved to October 13. Under PA-24-176, the dates left are February 12, 2027 for new applications and March 12, 2027 for resubmissions; applications are due by 5:00 PM local time of the applicant organization.


How K Award Review Differs From R01 Review

This is the most important conceptual shift for R01-experienced investigators applying for a K award for the first time.

In an R01 application, the research plan is the primary criterion. Reviewers ask: "Is this science compelling and rigorous?"

In a K award application, the candidate's development trajectory is the primary criterion. Reviewers ask: "Can this person become an independent investigator? Does the training plan, mentorship, and proposed research together create a realistic path to independence?"

K01 applications are scored on the career development review criteria in the parent K01 notice. A common mistake is assuming NIH's Simplified Review Framework applies: NOT-OD-24-010 (opens in a new tab) lists only research project grant codes such as R01, R03, R21, and U01, not K awards. The K criteria include:

  1. Candidate: Your academic preparation, research experience, publications, career goals, and commitment to a research career. This is heavily weighted in K award review - more so than in any R-mechanism.
  2. Career Development Plan and Career Goals: Grant experts have described this as "arguably the most important, yet most frequently marginalized element." What specific skills will you gain? What training activities will build those skills? What will you be able to do at the end of the award that you can't do now? The CDP needs to answer these questions concretely.
  3. Research Plan: The proposed research matters, but it's secondary to candidate development. The science needs to be appropriate for the training context - rigorous enough to be credible, scoped appropriately for the career stage.
  4. Mentor(s), Co-Mentors, and Collaborators: Mentor qualifications, track record in mentoring, and genuine commitment are all evaluated. A letter from a prominent PI who is too busy to actually mentor you will hurt your application.
  5. Environment and Institutional Commitment: Facilities, resources, and the strength of the chair's commitment letter. Reviewers look for concrete resources, not boilerplate descriptions.

The Career Development Plan: What Makes It Strong

The Career Development Plan is frequently the weakest section in K01 applications, because applicants write it last, quickly, after spending most of their effort on the research plan. That's backwards.

A strong CDP includes:

Specific, measurable milestones on a timeline. Not "attend grant writing workshops" - name the workshop, the date, and what skill it develops. Not "improve statistical methods" - specify the course (including institution and course number if applicable), the learning objectives, and how that training feeds into the research plan.

Research milestones aligned with publications. What paper will you have submitted by the end of Year 2? By Year 4? Reviewers want to see a realistic publication plan that demonstrates the K01 will produce a record that positions you for an R01.

A clear R01 submission target. By approximately the midpoint of Year 3 of a 5-year K01, you should be submitting or preparing to submit your first R01. The CDP should articulate this timeline explicitly. If you're not planning to submit an R01 until after the K01 ends, that's a problem.

Training activities that address identified skill gaps. The CDP should begin by acknowledging what you currently can't do and then map each training activity to closing a specific gap. Reviewers expect to see that the training was designed with intent, not assembled from a catalog of available opportunities.

A CDP that reads as "a perfunctory set of courses" with no clear skill-gap analysis - a phrase reviewers actually use - is one of the most common reasons for poor K award scores.


The Mentorship Plan: What Reviewers Evaluate

Your lead mentor needs to have active, independent extramural funding - ideally an R01 or equivalent - that's projected to continue through your K award period. A mentor without active funding can't credibly provide the training environment your CDP describes.

Co-mentors should provide distinct, non-overlapping expertise that genuinely complements your primary mentor. If your primary mentor is a molecular biologist and you're trying to gain clinical research skills, your co-mentor should be a clinician-scientist with direct patient-oriented research experience - not another molecular biologist.

Including too many mentors with overlapping expertise signals that you assembled a committee to impress reviewers rather than to actually develop specific skills.

The mentor's training record matters. How many trainees have the mentor supported to independent positions, faculty appointments, or their own R01 awards? Reviewers look for evidence of successful mentoring, not just a list of prior trainees.

The mentor statement must commit specific time - monthly meetings at minimum - and describe HOW mentoring will happen. "I will meet regularly with Dr. X and provide guidance" doesn't cut it. The statement should describe the structure of meetings, how the mentor will review manuscripts, how the mentor will provide access to collaborators, and what specific guidance the mentor is uniquely positioned to give.

For a detailed insider's perspective on K award applications, the JCI Insight guide at insight.jci.org/articles/view/191904 (opens in a new tab) is worth reading in full.


K-to-R01 Transition Statistics: What the Data Shows

According to a 2023 JAMA research letter (opens in a new tab) that used NIH RePORTER records for mentored K awardees in U.S. medical school departments (cohort 1997 to 2011), the 10-year K-to-R01-equivalent transition rate was about 39.9%. That means roughly 4 in 10 K awardees in the study went on to an R01-equivalent award within 10 years. The variation by department is significant:

  • Dermatology: 50.7% - highest department-level transition rate
  • Pathology: 44.3%
  • Internal Medicine: 41.4%
  • Family Medicine: 26.6% - lowest department-level rate

There's also a statistically significant gender gap: men transitioned at 41.5% and women at 37.7% (P=.002).

The study reports results by gender and department and pools the mentored K award types, so treat it as a benchmark, not as a K01 rate or a K99/R00 rate. If you're a late-stage postdoc deciding between K99/R00 and K01, decide on eligibility and the faculty-transition timeline, not on a conversion rate for one mechanism.

The practical timeline for maximizing your K-to-R01 transition: aim to submit your first R01 application by the midpoint of Year 3 of a 5-year K award. This gives you an A1 resubmission opportunity, if needed, while you're still within your funded period and have the protected time to address reviewer critiques.


Institute-Specific K01 Priorities

NIMH: Pays up to $90,000 in K01 salary and $50,000 in research support and encourages applicants to request no more than 4 years, according to NIMH's K01 page (opens in a new tab); a 5-year request without prior approval may be cut to 4. NIH's institute table adds that NIMH prioritizes mentored K applications from early-stage investigators before tenure.

NHLBI: NHLBI's FY2026 funding policy (opens in a new tab) says it does not have a payline or strict score cutoff. Funding decisions weigh peer review, advisory council input, and program priorities, so ask the program officer how your score compares rather than assuming a number.

NCI: NCI's diversity K01, PAR-24-316, was terminated early on November 25, 2024 (NOT-CA-25-011) and is expired. Check NCI's current career development announcements before planning around an NCI-specific K01.

NIDDK: K01 for basic and behavioral science researchers; K23 for clinician-scientists who work directly with human subjects. NIDDK supports postdocs and non-tenured junior faculty, and its K01 page (opens in a new tab) notes that a K01 awardee can add an NIDDK small grant (R03) of up to $75,000 a year in the last 2 years.

For all institutes, reading the specific FOA for the K01 mechanism you're targeting is essential. The eligibility range, salary cap, research cost supplement, and application requirements differ by institute and by specific FOA.


Can You Have an R01 and a K01 Simultaneously?

Not at the time you apply: current or former R01, P01 and P50 PDs/PIs can't apply for a K01 under PA-24-176. You can submit R01 applications at the same time as your K01 application, though; the parent says candidates "may submit research project grant (RPG) applications concurrently with the K application."

Once the K01 is active, an R01 doesn't end it. In the final 2 years of the award, you can keep the K01 at no less than 50% effort and charge the rest to the R01, provided your combined research effort stays at 75% or more and you get prior approval. If an R01 arrives earlier in the award or while the K01 is still under review, contact your program officer before you accept it.

You can see the full picture of how R01, R21, and R03 interact with K award eligibility in our comparison of NIH grant mechanisms.


What K Award Reviewers Actually Score

Here's what the FOA doesn't make obvious about how K01 applications are actually evaluated.

The career development plan matters more than the research plan, and most applicants get the ratio backwards. K awards are training awards. Reviewers are evaluating whether this award will turn you into an independent investigator, not whether your research will produce breakthrough results. K01 applications with scientifically brilliant research plans can score poorly when the career development section is generic: "I will attend seminars and learn new techniques." Contrast that with "In Year 1, I will complete a 3-month intensive training in single-cell RNA sequencing at Dr. Smith's lab (confirmed, see mentor letter), attend the Cold Spring Harbor Computational Genomics course (accepted for Summer 2027), and present preliminary findings at the ASHG annual meeting." That level of specificity in the training plan is what separates the 20th percentile from the 5th.

Your mentor's letter is secretly the most important document in the application. Reviewers read the mentor's letter to assess whether the mentoring relationship is real and substantive, not pro forma. A generic letter that says "I fully support Dr. Applicant and will meet with them regularly" gets a shrug. A letter that says "We will meet weekly for the first year (Tuesdays at 2pm, confirmed on both our calendars), I will provide access to my lab's existing dataset of 4,000 patient samples, and I will introduce them to my NIH program officer at the upcoming SFN meeting" tells reviewers this mentorship is real.

K01 to R01 conversion is the metric NIH tracks internally. NIH evaluates K mechanisms partly on whether awardees successfully transition to R01 funding. Build your K01 application around a clear R01 transition timeline: preliminary data collection in Years 1-2, R01 submission in Year 3, and independent lab launch in Year 4-5. Reviewers look for this trajectory explicitly.


How Grantsights Checked This Guide

Source review by Grantsights: we checked NIH Research Training and Career Development (opens in a new tab) pages, active Parent K01 NOFO branches (opens in a new tab), NIH peer review policy (opens in a new tab), institute participation language, Grants.gov (opens in a new tab), and USASpending.gov (opens in a new tab) before this update. The practical gap is that NIH tells you eligibility and review criteria, but it does not rank the hidden fit risks: institute participation, protected-time enforcement, mentor funding, and K-to-R timing.

Source checkedWhat it provesApplicant action
NIH Research Training and Career DevelopmentK01 sits inside the mentored career development seriesCompare K01 against K08, K23, K25, and K99/R00 before drafting
Active Parent K01 branchesClinical trial status changes the correct NOFOPick the trial status branch before building Specific Aims
K review criteria in the parent K01 noticeK review centers candidate, plan, mentor, and environmentTreat the career plan as a scored product, not an appendix
USASpending.govPrior K01 awards show institute patternsCheck award history for your institute and field

According to NIH, K awards require substantial protected research and career development effort, often 9 person-months for mentored mechanisms. According to NIH, many mentored K awardees must commit 75% effort unless an institute-specific exception applies. According to NIH peer review policy, review for most research project grants changed for applications due on or after January 25, 2025, and K reviewers still examine candidate, career plan, mentor, and institutional commitment evidence. According to Grants.gov, each active NOFO controls citizenship, clinical-trial status, and participating institutes. According to NIH, many mentored K mechanisms run 3 to 5 years depending on institute rules. According to USASpending.gov, prior award records can help confirm whether a target institute is actively issuing K01 awards in the topic area. For each institute's odds, see K01, K08, and K23 success rates by institute.

What Official Sources Don't Tell You

Official NIH pages make the K01 sound cleaner than it is. Based on our analysis, a K01 is a bad fit if the applicant already has an independent R01-level profile, cannot document 75% protected time, has a mentor without active funding, or needs a K99/R00-style faculty transition. For example, one applicant with a strong PhD record but no written department plan to reduce teaching would be vulnerable even with strong science, because reviewers can score the institutional commitment down. Use the Grantsights database to compare active K-series NOFO branches, and read each notice's eligibility section before you commit to a mechanism.

Sources


Award data for this program

Frequently Asked Questions

What is the difference between K01 and K23?

The K01 is for PhD researchers (in basic, behavioral, or clinical science) who need protected time to develop expertise in a new research area. The K23 is for physicians (MD or DO) who conduct patient-oriented research that involves direct interaction with human subjects. If you're a clinician working directly with patients as the primary subject of your research, start with the Parent K23 notices, with or without a clinical trial. If you're a PhD researcher pivoting to a new scientific area, it's K01.

How much money does the NIH K01 award provide?

Most institutes cap K01 salary at $75,000 to $100,000 a year plus fringe and pay $20,000 to $50,000 a year in research support, according to NIH's institute table for PA-24-176 (checked November 14, 2026). NIA pays $75,000 and $20,000; NHLBI $100,000 and $30,000; NIMH and NIDDK $90,000 each, with $50,000 and $25,000 in research support. NINDS and NLM pay more to faculty candidates. Awards run 3 to 5 years, and some institutes cap the K01 at 3 or 4. In NIH RePORTER, the median FY2026 K01 award was about $152,000 in total costs.

What does 75% protected time mean for a K01 award?

It means at least 9 person-months a year (75% of full-time professional effort) go to the K01's research and career development, and you need a full-time appointment at the applicant institution. The other 25% can be teaching, clinical work or other research. In the final 2 years of a 3- to 5-year mentored K, you can drop K effort to 50% if you become PD/PI of a peer-reviewed research award, as long as your combined research effort stays at 75% or more (NIH Extramural Nexus, June 2026).

Can I have an R01 and a K01 at the same time?

You can't apply for a K01 if you are or were PD/PI on an R01, P01 or P50 or held another major individual K award, under PA-24-176. Winning an R01 during the K01 is different: in the final 2 years of the award you can keep the K01, cut its effort to 50% and move the rest to the R01, with your program officer's prior approval. Past R03, R21, R34 and SBIR PIs stay eligible to apply.

Is there a years-since-degree limit for the K01?

No. The parent K01, PA-24-176, sets no limit on years since your doctorate. Some institutes set priorities instead: NICHD favors candidates within 6 years of finishing a postdoc or clinical fellowship, NIEHS favors those within 3 years of a first faculty job, and NIBIB funds junior faculty but not postdocs. NIDDK dropped its minimum and maximum postdoc years for applications from January 25, 2025 (NOT-DK-25-001).

What are the NIH K01 page limits?

The Specific Aims page is 1 page, and the Candidate section plus the Research Strategy share a combined 12-page limit. Mentor and co-mentor statements get 6 pages, letters of support from collaborators 6 pages, and the institutional environment and institutional commitment 1 page each. A resubmission introduction is 1 page. These come from NIH's Table of Page Limits, which the Parent K01 notice adopts; an institute-specific notice can set different limits.

What does 'ACT K01' mean?

No NIH program is called ACT K01. K01 is an NIH activity code, and none of the K01 announcements in the NIH Guide uses 'ACT' in its title. Note that NIH plans to replace the K01 code with KR1 for due dates on or after October 12, 2027, under NOT-OD-26-098.

What is the K-to-R01 transition rate for K award recipients?

A 2023 study in JAMA that used NIH RePORTER records for mentored K awardees in all U.S. medical school departments found a 10-year K-to-R01-equivalent transition rate of about 39.9% (cohort 1997 to 2011). It varied by department, from 50.7% in Dermatology to 26.6% in Family Medicine. Men transitioned at 41.5% and women at 37.7% (P=.002). The study pooled all mentored K award types in medical schools, so treat it as a benchmark rather than a K01-specific rate.

Last updated November 14, 2026. Corrected November 14, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.